Related Experiment Video
Updated: Feb 13, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Nurturing the Continuum of HIV Testing, Treatment and Prevention Matrix Cascade in Reducing HIV Transmission
1Implementation Science Unit, Wits Reproductive Health and HIV Institute (Wits RHI), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Insights
Treating all individuals with HIV, regardless of CD4 count, and providing prevention for high-risk partners significantly reduces HIV transmission. This approach is key to controlling HIV incidence and improving health outcomes.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- HIV morbidity, mortality, and infections continue to rise despite expanded antiretroviral therapy (ART) eligibility.
- Current ART eligibility criteria have shifted from CD4 ≤ 200 to CD4 ≤ 500 cells/mm³.
- A paradigm shift towards treating all HIV-positive individuals is proposed to mitigate HIV-related illnesses.
Purpose of the Study:
- To evaluate the impact of universal HIV treatment and prevention strategies on HIV incidence.
- To assess the effectiveness of providing ART to all HIV-positive individuals irrespective of CD4 count.
- To determine the role of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for high-risk HIV-negative partners.
Main Methods:
- A literature review was conducted to identify evidence-based ART and HIV prevention interventions.
- Included studies were published in English and indexed in major journals.
- A mathematical model was used to simulate HIV incidence, assuming a baseline rate of 1.2 per 100 person-years.
Main Results:
- HIV transmission was reduced from 1.2 to 1.032 per 100 person-years within 6 months in the model.
- The model indicated a significant reduction in HIV incidence.
- The combined protective effect of ART for HIV-positive partners and PrEP/PEP for HIV-negative partners demonstrated an 86% probability of preventing transmission.
Conclusions:
- Implementing universal ART for all HIV-positive individuals and prevention strategies for high-risk partners can significantly reduce HIV incidence.
- This integrated approach is crucial for controlling HIV transmission and reducing HIV-related morbidity and mortality.
- Sustained adoption of these policies may lead to better control of HIV genotypes and opportunistic infections.
Background:
Despite the shift in antiretroviral therapy (ARVs) eligibility cascade from CD4 ≤ 200 to CD4 ≤ 350 to CD4 ≤ 500 mm3, HIV related morbidity and mortality continue to escalate annually, as do HIV infections. The new paradigm of treatment for all HIV positives individual irrespective of CD4 count may significantly reduce HIV and related illnesses. The author assumes that all HIV infected partners should be eligible for HIV treatment and care, irrespective of CD4 count. A second assumption is that high risk HIV negative partners have free access to continuum of HIV pre-exposure prophylaxis (PrEP), post exposure prophylaxis (PEP) and other prevention packages.
Methods:
A literature review search was used to extract evidence-based ARVs-HIV treatment and prevention interventions among HIV positives and high risk partners respectively. Only articles published in English and indexed in journal nuclei were used for the study. The information was used to nurture understanding of HIV treatment and prevention approaches as well as HIV incidence multiplier effect among HIV serodiscordant partners. The imputed HIV incident reference was assumed at 1.2 per 100 person-years (2). This was based on the imputation that retention in care, adherence and other predetermined factors are functions of an effective health care delivery system.
Result:
The model showed a reduced HIV transmission from 1.2 per 100 person-years to 1.032 per 100 person-years in 6 months. The average threshold period of HIV suppressed partners on ARVs to an undetectable level. The combined multiplier protective-effect probability of transmitting HIV from HIV positive partners on ARVs-suppressed viremic load to HIV negative partners on PrEP/PEP-prevention was detected at 86.
Conclusion:
The model showed a significant reduction in HIV incidence. Placing serodiscordant sexual partners in HIV treatment and prevention plays a significant role in reducing and controlling HIV infection. Therefore, the policy of enrolling all HIV positives irrespective of CD4 count on ARVs and high risk partners on prevention if adopted and sustained may underpin reduction and control of HIV genotype and HIV related morbidity, mortality and opportunistic infections.
More Related Videos
Related Concept Videos
Nature and Nurture
Intracellular Signaling Cascades
The Extracellular Matrix
Rab Cascades
MAPK Signaling Cascades
Cascaded Op Amps
In a cascaded system, each op-amp is referred to as a stage. The output of one stage drives the input of the subsequent stage. As the input signal passes through...

